Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)
Trademark/Service Mark Application, Principal Register
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a cannabis leaf between the words BLACK LABEL all displayed inside a rectangular border.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
687 x 251
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Tweed Inc.
*STREET
1 Hershey Drive
*CITY
Smiths Falls, Ontario
*COUNTRY
Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
K7A0A8
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
003
*IDENTIFICATION
Cosmetic preparations against sunburn; face and body creams; non-medicated preparations for the care of hair; non-medicated preparations for
the care of skin; sun screen preparations; sun-tanning preparations
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
1798250
FOREIGN APPLICATION
COUNTRY
Canada
FOREIGN FILING DATE
08/30/2016
INTENT TO
PERFECT 44(d)
At this time, the applicant does NOT intend to rely on §44(e) as a basis for registration, but wishes only to assert a valid claim of priority. The
application should not be suspended to await the submission of the foreign registration.
INTERNATIONAL CLASS
005
*IDENTIFICATION
analgesic preparations; antibiotic preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;
pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations
for the treatment of glaucoma; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries;
pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa,
anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia;
pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of the
musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for wounds; topical
anesthetics; analgesic preparations; antibiotic preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the relief of
pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical
preparations for the treatment of headaches; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of
inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism;
pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of
skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue
diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for wounds; topical anesthetics;delivery systems in the nature of topical
applications, namely, foams, gels, creams, sprays, lotions and ointments which act as a base and prepare the skin to receive therapeutic preparations that are absorbed into the blood stream through
the skin;
FILING BASIS
SECTION 1(b)
FILING BASIS
SECTION 44(d)
FOREIGN APPLICATION NUMBER
1798250
FOREIGN APPLICATION
COUNTRY
Canada
FOREIGN FILING DATE
08/30/2016
INTENT TO
PERFECT 44(d)
At this time, the applicant does NOT intend to rely on §44(e) as a basis for registration, but wishes only to assert a valid claim of priority. The
application should not be suspended to await the submission of the foreign registration.
ATTORNEY INFORMATION
NAME
Mark Mutterperl
FIRM NAME
Zeisler PLLC
STREET
750 Third Avenue
CITY
New York
STATE
New York
COUNTRY
United States
ZIP/POSTAL CODE
10017
PHONE
917-410-7941
EMAIL ADDRESS
mark@zeisler-law.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
CORRESPONDENCE INFORMATION
NAME
Mark Mutterperl
FIRM NAME
Zeisler PLLC
STREET
750 Third Avenue
CITY
New York
STATE
New York
COUNTRY
United States
ZIP/POSTAL CODE
10017
PHONE
917-410-7941
*EMAIL ADDRESS
mark@zeisler-law.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
550
*TOTAL FEE PAID
550
SIGNATURE INFORMATION
SIGNATURE
/Mark Mutterperl/
SIGNATORY'S NAME
Mark Mutterperl
SIGNATORY'S POSITION
Attorney of Record, New York bar member
SIGNATORY'S PHONE NUMBER
917-410-7941
DATE SIGNED
02/28/2017
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)
Trademark/Service Mark Application, Principal Register
Serial Number:87353390
Filing Date:02/28/2017
To the Commissioner for Trademarks:
MARK: BLACK LABEL (stylized and/or with design, see mark)
The literal element of the mark consists of BLACK LABEL.
The applicant is not claiming color as a feature of the mark. The mark consists of a cannabis leaf between the words BLACK LABEL all displayed inside a rectangular border.
The applicant, Tweed Inc., a corporation of Canada, having an address of
1 Hershey Drive
Smiths Falls, Ontario K7A0A8
Canada
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 003: Cosmetic preparations against sunburn; face and body creams; non-medicated preparations for the care of hair; non-medicated
preparations for the care of skin; sun screen preparations; sun-tanning preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Canada application number 1798250, filed 08/30/2016.
INTENT TO PERFECT 44(d) : At this time, the applicant does NOT intend to rely on §44(e) as a basis for registration, but wishes only to assert a valid claim of priority. The application should not be
suspended to await the submission of the foreign registration.
International Class 005: analgesic preparations; antibiotic preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal
diseases; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical
preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and
injuries; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia
nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia;
pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of the
musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for wounds; topical
anesthetics; analgesic preparations; antibiotic preparations; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the relief of
pain; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical
preparations for the treatment of headaches; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of
inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism;
pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of
skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue
diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for wounds; topical anesthetics;delivery systems in the nature of topical
applications, namely, foams, gels, creams, sprays, lotions and ointments which act as a base and prepare the skin to receive therapeutic preparations that are absorbed into the blood stream through
the skin;
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Canada application number 1798250, filed 08/30/2016.
INTENT TO PERFECT 44(d) : At this time, the applicant does NOT intend to rely on §44(e) as a basis for registration, but wishes only to assert a valid claim of priority. The application should not be
suspended to await the submission of the foreign registration.
The applicant's current Attorney Information:
Mark Mutterperl of Zeisler PLLC 750 Third Avenue
New York, New York 10017
United States
917-410-7941(phone)
mark@zeisler-law.com (authorized)
The applicant's current Correspondence Information:
Mark Mutterperl
Zeisler PLLC
750 Third Avenue
New York, New York 10017
917-410-7941(phone)
mark@zeisler-law.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Mark Mutterperl/ Date: 02/28/2017
Signatory's Name: Mark Mutterperl
Signatory's Position: Attorney of Record, New York bar member
Payment Sale Number: 87353390
Payment Accounting Date: 03/01/2017
Serial Number: 87353390
Internet Transmission Date: Tue Feb 28 19:37:36 EST 2017
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-201702281937362
86236-87353390-5808fe5fd16e1a0708abe586a
9e1cbc4941719dfd89ec6f4d6935f6f6a2cb992f
1-CC-8316-20170228192840945107